Selvita informed about signing a preliminary contract to purchase another plot of land to expand its own laboratory space and secure further organic growth in Krakow, Poland. The integrated departments providing drug discovery services, operating in Krakow, Poznan, and Zagreb, will be led by Dr. Adrijana Vinter, who takes on a role of the Global Head of Drug Discovery and joins Selvita Management Board. Prior to that, for the past four years, Dr. Vinter has held the position of Managing Director at Fidelta.

The Company intends to also integrate its business development and sales activities. Dr. Milosz Gruca, who will assume the position of Chief Commercial Officer, Executive Vice President, will be managing teams responsible for the development and sales of the integrated Selvita and Fidelta services offer in the area of drug discovery and development. Growing Group's scale of operations and its further development plans have led to creation of the Chief Operating Officer function, assumed by Dr. Miroslawa Zydron, the current Chemistry Department Director.

Dr. Zydron will be responsible for the Group's operational activities, investments, and infrastructure management.